← Back to catalogue

Birlinn BCR-ABL1 p210 IS Control Panel C240

FDA UDI

Class II (US FDA UDI)

by Mmqci

Identity

Trade Name
Birlinn BCR-ABL1 p210 IS Control Panel C240 FDA UDI
Generic Name
Philadelphia chromosome/BCR-ABL transcript IVD, control FDA UDI
Device Name
External quality controls to monitor the performance of in vitro laboratory nucleic acid detection and quantification of BCR-ABL1 fusion gene using molecular test systems. FDA UDI
Model / Reference
v.00 FDA UDI
Description
External quality controls to monitor the performance of in vitro laboratory nucleic acid detection and quantification of BCR-ABL1 fusion gene using molecular test systems. FDA UDI

Identifiers

Catalog Number
C240 FDA UDI
Primary DI / UDI-DI
00852720008367 FDA UDI
FDA Product Code
QIG FDA UDI
GMDN Term
Philadelphia chromosome/BCR-ABL transcript IVD, control FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
866.5910 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

Yes

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Philadelphia chromosome/BCR-ABL transcript IVD, control

Birlinn BCR-ABL1 p210 IS Control Panel C240 by Mmqci — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Philadelphia chromosome/BCR-ABL transcript IVD, control.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Mmqci

Sources (1)

  • FDA UDI c46f0060-5a5f-4b33-9736-3d2322707fa6 36 fields · synced May 30, 2026